It was a pleasure speaking on Decoding Molecular Pathology at the Dr M. Krishnan Nair International Clinical Oncology Symposium (MKN ICOS) on Lung Cancer organised by Regional Cancer Centre, Thiruvananthapuram

Imagine doing everything “right.” You eat reasonably well, you stay active, you don’t smoke. And yet, your cholesterol stays stubbornly high—sometimes very high. For many people, this isn’t about willpower or lifestyle. It’s about genetics.

geknowmics.karkinos.in/2026/01/22/t...

Wellness DNA tests have become incredibly popular. With a simple saliva sample, you can receive reports that claim to reveal everything from your ideal diet to your fitness “type,” vitamin needs, and even some health risks.

geknowmics.karkinos.in/2026/01/20/w...

Today, something remarkable is happening in hospitals and clinics around the world: doctors can read nearly all of a person’s genetic instruction manual in days or sometimes even hours.

geknowmics.karkinos.in/2026/01/19/t...

What Is Carrier Screening and Who Should Consider It?
A carrier is usually healthy and has no symptoms, but can still pass a non-working gene copy to their child. Read more at geknowmics.karkinos.in/2026/01/16/w...

How Whole Genome Sequencing Could Change Preventive Healthcare for Everyone share.google/rBpwg9HXywlm...

What is a “Variant of Uncertain Significance (VUS)”—and What Should You Do About It? – Geknowmics share.google/e2trmPJ2Jqyj...

Pharmacogenomics is the study of how your genes affect the way your body responds to medicines. In simple terms, it helps explain why the same drug can work well for one person, cause side effects in another, and do very little for someone else.

geknowmics.karkinos.in/2026/01/13/w...

Whole genome sequencing now costs less than a smartphone, reads 3B letters, and flags disease risk years early. Surprise: your DNA is stable—medicine isn’t.

Whole Genome Sequencing benefits everyone.
It uncovers genetic risks, predicts treatment responses, and enables evidence-based prevention. More than a test, it is a once-in-a-lifetime resource that can guide truly personalized care across your entire lifespan.

It was a pleasure speaking on #Pharmacogenomics at the #PrecisionMedicine symposium at AIG Hospitals, Hyderabad

#genomics #wholegenomesequencing #precisionmedicine

Memories from the session in September on Converging Genetics - What , Why and When of #WholeGenomeSequencing at Galle Medical College organised by Galle Medical Association.
Thanks Dr. Lahiru Prabodha for the invitation and the memorable event.

Preparedness is not about predicting the future, but being ready for it in every form.

Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Read the latest Editorial published in TCRT
@tcrtcancer.bsky.social - The Bharat Cancer Genome Atlas: Charting India's Unique Cancer Landscape for Precision Oncology
journals.sagepub.com/doi/10.1177/...

@vinodscaria.bsky.social @karkinoshealth.bsky.social

#CancerGenomics #PrecisionOncology

Yesterday, I had the pleasure of taking a workshop on Clinical Genomics and Genetic Variant Interpretation, empowering clinicians and residents with the latest genomics insights.
It is indeed exciting times for genomics in healthcare #GenomicsInMedicine #midtermPHOCON2025

Making A Case for Genomic Newborn Screening in India Almost 1 in 250 children born each year in India has a treatable genetic disease. Genetic screening at birth is nonexistent in public healthcare system

A Healthier Start: Making A Case for Genomic Newborn Screening in India
sciencechronicle.in/2025/07/14/a...

A genomic view of DNA damage in chemotherapy Seventeen of 23 individuals exposed to chemotherapy had far more genetic mutations than could be explained by normal aging. Even more revealing was the discovery of eight unique mutational signatur…

Researchers at Sanger Institute in the UK have used genomic tools to unravel the chemotherapy mutograph in hematopoietic stem cells

Read the complete article at sciencechronicle.in/2025/07/08/a...

Chemotherapy is a double edged sword and while effective against a number of cancers, and often the first line of therapy in many, can cause significant genetic mutations in healthy cells, and sometimes increased risk of new cancers over a long time.
1/2

Whole-genome sequencing of 2,762 Indians has unravelled the layers of ancestry, high intermixing with Neanderthals and Denisovans. This along with high endogamy in India could potentially result in harmful mutations in some groups.

share.google/EzZEcHF47IdT...

Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program | Circulation: Genomic and Precisio... BACKGROUND: This study aimed to evaluate the prevalence of pathogenic/likely pathogenic cardiomyopathy variant carriers in a multiancestry US population and examine the risk of adverse clinical outcom...

Carriers face a significantly higher risk (2-4x) of heart failure, cardiomyopathy, and arrhythmias.

This underscores the potential of genetic screening for early detection and intervention.
www.ahajournals.org/doi/10.1161/...

💔 New research from the All of Us Program reveals that 1.2% of South Asians carry key cardiomyopathy gene variants and this is almost 50% more than the frequency in people with European or African ancestry and more than double the frequency in people with East Asian ancestry

Hi. Would you be able to share a preprint or PDF at drvinod(at)gmail.thanks in advance.